Internal Medicine, Endocrinology, Diabetes, & Metabolism · Birmingham, AL
NPI
1801076500
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
50 Medical Park Dr E Ste 158
Birmingham, AL, 35235
Phone (205) 838-3156
Groups this clinician bills Medicare through
Medicare paid, 2024
$158K
10,049 services
Medicare patients, 2024
271
Average age 72
Drug cost, 2024
$3.1M
8,125 prescriptions
Company payments, 2025
$15K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Janelle M Townes was code J0897 (injection, denosumab, 1 mg), 2,100 times for 22 patients. In total Janelle M Townes billed 10,049 services in 16 codes, and Medicare paid $158K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,100 | 22 | $20.56 | $43K |
| 99214 Office E&M - Established | Office | 453 | 207 | $84.39 | $38K |
| 83036 Blood Count | Office | 337 | 154 | $9.40 | $3,167 |
| 95251 Test - Miscellaneous | Office | 234 | 91 | $25.08 | $5,870 |
| 96372 Injection Administration | Office | 68 | 27 | $9.93 | $675 |
| 99213 Office E&M - Established | Office | 47 | 42 | $51.51 | $2,421 |
| 99204 Office E&M - New | Office | 39 | 39 | $90.75 | $3,539 |
| 99203 Office E&M - New | Office | 16 | 16 | $70.02 | $1,120 |
| 99215 Office E&M - Established | Office | 12 | 12 | $84.84 | $1,018 |
By year: 2022 $98K for 5,911 services; 2023 $123K for 7,872 services; 2024 $158K for 10,049 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 337 | 154 | $9.40 | $3,167 |
Medicare prescription drug claims, 2024
In 2024, the drug Janelle M Townes prescribed most often to Medicare patients was Ozempic (Semaglutide), with 634 prescriptions and refills. In total Janelle M Townes wrote 8,125 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 634 | 752 | 124 | $709K |
| Levothyroxine Sodium Generic | 520 | 1,143 | 141 | $7,934 |
| Mounjaro Tirzepatide | 496 | 532 | 76 | $558K |
| Atorvastatin Calcium Generic | 344 | 908 | 112 | $4,325 |
| Jardiance Empagliflozin | 294 | 428 | 63 | $242K |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 242 | 326 | 55 | $47K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 233 | 388 | 69 | $18K |
| Pioglitazone Hcl Generic | 214 | 571 | 66 | $3,501 |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 208 | 291 | 48 | $59K |
| Rosuvastatin Calcium Generic | 204 | 568 | 70 | $4,874 |
| Metformin Hcl Generic | 188 | 405 | 54 | $1,438 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 183 | 345 | 59 | $19K |
| Gabapentin Generic | 172 | 239 | 43 | $2,513 |
| Methimazole Generic | 165 | 374 | 47 | $1,743 |
| Glimepiride Generic | 164 | 425 | 59 | $1,511 |
Brand drugs: 4,380 claims; generic drugs: 3,032 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Janelle M Townes $15K ($15K in general payments such as food, travel and fees) from 20 companies. The largest payer was Lilly USA, LLC with $10K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 25 | $10K |
| Abbott Laboratories ABT | 9 | $2,062 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $781 |
| Novo Nordisk Inc NVO | 10 | $540 |
| Medtronic, Inc. MDT | 4 | $261 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $239 |
| Amgen Inc. AMGN | 11 | $137 |
| Tandem Diabetes Care, Inc. TNDM | 7 | $128 |
| Beta Bionics, Inc. BBNX | 4 | $88.98 |
| Sanofi-Aventis U.S. LLC SNY | 5 | $86.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.